Welcome : Guest

Caladrius Biosciences, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Caladrius Biosciences, Inc., which is principally involved in Cell Therapy Business. Illustrated with 42 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64970
Price: $2100
Company Type: Public
Pages: 45
Date: January 2017
Market Data Tables: 42

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Caladrius Biosciences, Inc.’s Revenues by Category (2015) in Percentage for Clinical Services, Clinical Services Reimbursable, Processing and Storage Services, and Others......3
Immunotherapy......5
Table 2: No. of Patients for Immunotherapy by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Europe, North America, and Others......5
Table 3: No. of Patients for Immunotherapy by Age Group in the US (2015) - Percentage Market Share Breakdown by Value for 0-4 Patient Pool, 10 - 14 Patient Pool, 15 - 19 Patient Pool, 5-9 Patient Pool, Adult Patient Pool (over 65), and Adult Patient Pool (under 65)......6
Table 4: Immunotherapy Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Subcutaneous, and Sublingual......7
Table 5: Immunotherapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union, United States and Rest of the World......8
Ischemic Stroke Emergent Large Vessel Occlusion (ELVO)......9
Table 6: Ischemic Stroke Emergent Large Vessel Occlusion (ELVO) Market in the US (2015-2020) in '000 US$......9
Table 7: Ischemic Stroke Emergent Large Vessel Occlusion (ELVO) Market in Europe (2015-2020) in '000 US$......10
Melanoma......11
Table 8: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......11
Table 9: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......12
Diabetes......13
Table 10: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......13
Table 11: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......14
Table 12: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......15
Table 13: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......16
Table 14: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......17
Table 15: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......18
Table 16: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......19
Table 17: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......20
Table 18: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......21
Table 19: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......22
Diabetes Drugs......23
Table 20: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......23
Table 21: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......24
Table 22: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......25
Table 23: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......26
Table 24: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......27
Table 25: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......28
Table 26: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......29
Table 27: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......30
Table 28: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......31
Table 29: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......32
Table 30: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......33
Non-Insulin Anti-Diabetic Drugs......34
Table 31: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......34
Diabetic Macular Edema (DME)......35
Table 32: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......35
Table 33: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......36
Diabetes Drugs......37
Table 34: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......37
Table 35: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......38
Table 36: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......39
Sitagliptin/Metformin......40
Table 37: Market Shares of Leading Sitagliptin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Istavel and Januvia......40
Table 38: Market Shares of Leading Sitagliptin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd.......41
Table 39: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......42
Table 40: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......43
Metformin......44
Table 41: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......44
Ischemic Stroke Neurovascular Device......45
Table 42: Market Shares of Leading Ischemic Stroke Neurovascular Device Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Covidien Public Limited Company, and Stryker Corporation......45